Artificial intelligence continues to make rapid inroads into the heavily regulated Life Sciences industry, as many C-suite executives have embraced the technology to improve operational efficiency. In Episode 10 of The AI Arena, our host Sean skates to the puck alongside Manny Tzavlakis, Founder and Managing Partner at HELIO, a consulting firm which works with Life Sciences organizations that use generative AI to optimize their compliance, commercial, medical, and patient services. Manny offers our listeners key insights on how his clients are using AI for communications monitoring and policy management, two critical facets of pharmaceutical and medical device companies that need to be handled with care. Don’t miss this timely follow-up Life-Sciences episode to Sean’s conversation with Frank Traina, who highlighted how AI can mitigate increasing compliance costs and increase the speed of regulatory submissions in the industry.